ADMA BIOLOGICS, INC. Annual Cost of Revenue in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Adma Biologics, Inc. quarterly/annual Cost of Revenue history and growth rate from 2016 to 2023.
  • Adma Biologics, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $60.2M, a 41.2% increase year-over-year.
  • Adma Biologics, Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $196M, a 20.5% increase year-over-year.
  • Adma Biologics, Inc. annual Cost of Revenue for 2023 was $169M, a 42.5% increase from 2022.
  • Adma Biologics, Inc. annual Cost of Revenue for 2022 was $119M, a 48.9% increase from 2021.
  • Adma Biologics, Inc. annual Cost of Revenue for 2021 was $79.8M, a 30.1% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $169M +$50.5M +42.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $119M +$39M +48.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $79.8M +$18.5M +30.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $61.3M +$21.8M +55.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 $39.5M -$2.69M -6.38% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 $42.2M +$13M +44.7% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
2017 $29.2M +$27.6M +1715% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-13
2016 $1.61M Jan 1, 2016 Dec 31, 2016 10-K 2018-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.